Enhanced Understanding of Procalcitonin Utilization as an Infection Biomarker in Non-Hodgkin's Lymphoma
Clinical Laboratory · 2026 · 72 (03/2026)
DOI: 10.7754/clin.lab.2025.250418 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Laboratory, 2026. Verfasst von Limei Chen und 8 weiteren Autor:innen. Hauptthemen laut MEDLINE: Procalcitonin, Lymphoma, Non-Hodgkin, Calcitonin.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Chen, L., Wu, Z., Chen, N., Xin, N., Huo, R., Qiu, S., Zhou, Z., Cui, Z., & Xiao, Z. (2026). Enhanced Understanding of Procalcitonin Utilization as an Infection Biomarker in Non-Hodgkin's Lymphoma. Clinical Laboratory, 72(03/2026). https://doi.org/10.7754/clin.lab.2025.250418
Vancouver
Chen L, Wu Z, Chen N, Xin N, Huo R, Qiu S, et al. Enhanced Understanding of Procalcitonin Utilization as an Infection Biomarker in Non-Hodgkin's Lymphoma. Clinical Laboratory. 2026;72(03/2026). doi:10.7754/clin.lab.2025.250418
BibTeX
@article{Chen2026,
author = {Chen, Limei and Wu, Zhihui and Chen, Ningbin and Xin, Na and Huo, Ran and Qiu, Shuqian and Zhou, Zhifeng and Cui, Zhaolei and Xiao, Zhenzhou},
title = {Enhanced Understanding of Procalcitonin Utilization as an Infection Biomarker in Non-Hodgkin's Lymphoma},
journal = {Clinical Laboratory},
year = {2026},
volume = {72},
number = {03/2026},
doi = {10.7754/clin.lab.2025.250418}
}
EUVIMED